By Sophie Lindqvist

RealSelf has released its 2025 cosmetic surgery trend data — the platform's look at which aesthetic procedures pulled the most patient interest this year and which categories are projected to gain ground in 2026.

The data surfaced through The Dermatology Digest, which carried the headline "New RealSelf Cosmetic Surgery Trend Data: Which Procedures Surged in 2025, and What's in Store for 2026?" The release functions as a year-end briefing for RealSelf's patient audience and the practices that market to it.

What does the data set out to answer?

Two questions, framed directly in the headline: which cosmetic procedures pulled the most patient interest over 2025, and which categories look set to gain ground in 2026. The release lands as practices close out the calendar year and lock in next year's marketing and device-purchase plans.

For a dermatology office running injectables, energy-based devices or body contouring, the second question — the 2026 outlook — usually matters more than the retrospective 2025 ranking. The retrospective tells you what just happened. The forecast is what changes a budget.

Why does RealSelf's data get attention?

The platform draws on signals from prospective patients in the consideration phase — the segment comparing specific procedures, providers and price points. Trend reports that draw on that traffic tend to pre-figure the consult calendar by several months. That sits between claims data, which is comprehensive but slow, and social listening, which is fast but noisy.

For aesthetic practices, that lead time has direct operational value. The window between an emerging consumer trend and a saturated local market can run anywhere from a few months to a year. RealSelf's data is one of the earlier reads in that cycle.

What's in store for 2026?

The 2026 outlook is the section practices will mark up first. A platform-level forecast gives operators lead time on staffing, device inventory and patient education. If a category is heating in search traffic and consultation requests, practices can pre-build assets, train teams and seed campaigns before competitors flood the same channel.

The 2025 retrospective still matters. It confirms which categories held momentum versus which spiked and faded. That distinction matters when you're deciding whether to add a new device, expand an injectable menu, or double down on what's already converting.

What does this change for a dermatology practice?

Practices that follow the report will read it against their own consult logs, not as a stand-alone forecast. RealSelf's audience is a self-selecting patient pool, and the rankings reflect consumer curiosity, not necessarily the patient mix any given practice will see walk through the door.

The 2026 outlook also lines up with planning season. Operators finalizing next year's budget, marketing calendar and capital purchases over the coming weeks have a short window to fold the platform's trend signals into those decisions.

The full 2025 trend data and the 2026 outlook are available through The Dermatology Digest's coverage. Expect category-by-category breakdowns as the platform parses the rest of its year-end data and the post-holiday consult numbers firm up.